EconPapers    
Economics at your fingertips  
 

Refractoriness of STING therapy is relieved by AKT inhibitor through effective vascular disruption in tumour

Seung-hwan Jeong, Myung Jin Yang, Seunghyeok Choi, JungMo Kim and Gou Young Koh ()
Additional contact information
Seung-hwan Jeong: Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology
Myung Jin Yang: Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology
Seunghyeok Choi: Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology
JungMo Kim: Center for Vascular Research, Institute for Basic Science
Gou Young Koh: Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology

Nature Communications, 2021, vol. 12, issue 1, 1-18

Abstract: Abstract Stimulator of interferon genes (STING) promotes anti-tumour immunity by linking innate and adaptive immunity, but it remains unclear how intratumoural treatment with STING agonists yields anti-tumour effects. Here we demonstrate that intratumoural injection of the STING agonist cGAMP induces strong, rapid, and selective apoptosis of tumour endothelial cells (ECs) in implanted LLC tumour, melanoma and breast tumour, but not in spontaneous breast cancer and melanoma. In both implanted and spontaneous tumours, cGAMP greatly increases TNFα from tumour-associated myeloid cells. However, compared to spontaneous tumour ECs, implanted tumour ECs are more vulnerable to TNFα-TNFR1 signalling-mediated apoptosis, which promotes effective anti-tumour activity. The spontaneous tumour’s refractoriness to cGAMP is abolished by co-treatment with AKT 1/2 inhibitor (AKTi). Combined treatment with cGAMP and AKTi induces extensive tumour EC apoptosis, leading to extensive tumour apoptosis and marked growth suppression of the spontaneous tumour. These findings propose an advanced avenue for treating primary tumours that are refractory to single STING agonist therapy.

Date: 2021
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-021-24603-w Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-24603-w

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-021-24603-w

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-24603-w